UNMC receives another $3.5 million in stimulus funds
October 2, 2009
Nelson: $17 million in medical research funding coming to Nebraska
Press release from U.S. Senator Ben Nelson
September 30, 2009
UNMC's stimulus research funds surpass $5 million
September 4, 2009
UNMC receives more than $3 million in recovery act funds
August 5, 2009
UNMC received $8,000,000 through NIH’s National Center for Research Resources to renovate the Eppley Cancer Institute building. (PI: Ken Cowan, M.D., Ph.D.)
UNMC received $556,414 to expand cardiovascular research by hiring newly-independent investigators to determine the mechanisms responsible for the deterioration of cardiovascular function in patients with chronic heart failure. (PI: Irving Zucker, Ph.D.)
UNMC’s Eppley Cancer Institute received $242,673 to improve the efficiency and effectiveness of the clinical trials process by increasing clinical trials and cancer registries, increasing the number of the collected biospecimen samples, and improving the quality of the collected data. (PI: Ken Cowan, M.D., Ph.D.)
Oluwatoyin Asojo, Ph.D., assistant professor, pathology and microbiology, received $54,000 to better understand the mechanism of cancer drug transport and drug resistance.
Hamid Band, M.D., Ph.D., professor and director of the Center for Breast Cancer Research, received $348,002 to enhance understanding of cancer development with the hopes of creating new therapeutic agents against cancer.
Surinder Batra, Ph.D., professor, biochemistry and molecular biology, received $133,919 to understand the spread of lethal pancreatic cancer cells, in order to develop novel therapeutics for advanced stage patients.
Jeff Bose, Ph.D., post-doctoral research associate in pathology and microbiology, received $47,210 to study staph aureus bacteria with the goal of preventing infections and bacterial resistance to antibiotics.
Julia Bridge, M.D., professor, pathology and microbiology, and James Anderson, Ph.D., professor, biostatistics received subcontracts of $213,196 and $61,645 respectively to develop a clinical tool to determine optimal treatment for children with rhabdomyosarcoma.
Liliana Bronner, program associate, Rural Health Education Network, received $199,552 for an existing program that enables students and residents to serve clinical rotations on multidisciplinary health care teams in underserved communities.
Steven Caplan, Ph.D., associate professor, biochemistry and molecular biology, was awarded $212,273 to study endocytic recycling, which impacts diseases such as cancer and diabetes.
Pamela Carmines, Ph.D., professor & graduate director, cellular/integrative physiology, received $98,780 to study new therapeutic strategies for improving renal function in a variety of renal and cardiovascular diseases.
Carol Casey, Ph.D., professor of internal medicine, received $499,999 to study alcohol-induced liver disease, with a plan to identify therapeutic strategies to reduce its severity and progression.
Wing C. Chan, M.D., professor of pathology, received $369,275 to perform gene expression profiling to study uncommon tumors.
Pi-Wan Cheng, Ph.D., professor, biochemistry and molecular biology, received $468,688 to characterize regulation of gene expression to develop new therapies for chronic respiratory diseases such as cystic fibrosis, and $185,625 to develop therapies for lung and gastrointestinal diseases.
James Eudy, Ph.D., assistant professor, genetics, cell biology & anatomy, received $500,000 to purchase a genome analyzer that will be used in studies related to breast cancer, HIV, lymphoma, methamphetamine abuse, infectious disease, neurological and respiratory disorders, and disorders of language and learning.
Paul Fey, Ph.D., associate professor and associate director, pathology/microbiology, received $412,854 to study staphylococcus bacteria's resistance to antibiotics.
Howard Gendelman, M.D., professor, internal medicine, received $67,211 to study HIV, dementia, and biomarker discovery using proteomics.
Maurice Godfrey, Ph.D., associate professor, pediatrics, and his team received $100,000 to expand their science education activities to teachers and students on six Indian reservations in Nebraska and South Dakota.
Karen Gould, Ph.D., assistant professor, genetics, cell biology and anatomy, received $108,000 to determine how tamoxifen, a drug commonly used to treat and prevent breast cancer, promotes colon cancer, with the hopes of developing new therapies for breast cancer that do not increase colon cancer risk.
Neena Haider, Ph.D., assistant professor, genetics, cell biology & anatomy, received $354,750 to identify genes that can correct retinal disease.
Tsuneya Ikezu, M.D., Ph.D., professor, pharmacology and experimental neuroscience; received $371,250 to study how HIV can induce early onset of Alzheimer's disease and to discover the role of anti-inflammatory drugs in preventing age-related brain disorders.
Thomas Jerrells, Ph.D., professor, pathology and microbiology, received $23,760 to study the effects of chronic alcohol abuse on viral lung infections.
Keith Johnson, Ph.D., professor, college of dentistry, received $400,000 to support two collaborative projects related to oral health between members of the Nebraska Center for Cellular Signaling, with the goal of developing the projects into independently funded research programs.
Jennifer Larsen, M.D., professor of internal medicine, received $99,955 to determine nontraditional risk factors for heart disease after kidney transplantation.
David Li, Ph.D., associate professor, biochemistry and molecular biology, received $1,028,456 to prevent and treat cataracts and other ocular diseases.
Xu Luo, Ph.D., assistant professor, Eppley Institute, was awarded $101,371 to study cell death in an effort to design new therapeutic agents against cancer.
Luis Marky, Ph.D., professor, pharmaceutical sciences, received $125,000 to purchase a calorimeter, which will benefit the research of UNMC’s Colleges of Medicine and Pharmacy, and the Eppley Cancer Institute.
Kaleb Michaud, Ph.D., assistant professor, rheumatology, received a $78,218 subcontract to study clinical and cost-effective rheumatoid arthritis biologics to determine the best therapy for patients.
Robert Norgren, Ph.D., professor, genetics, cell biology and anatomy, received $538,868 for gene sequencing to facilitate further biomedical research in areas including: neuroscience, developmental disorders, and HIV/AIDS.
James O’Dell, M.D., professor, rheumatology, received an $89,034 subcontract to better understand molecular development and treatment response to rheumatoid arthritis drugs in order to predict which drugs will work best in individual patients.
Jill Poole, M.D., assistant professor, internal medicine, received $106,660 to study and prevent lung disease from chronic agricultural dust inhalation, with the hopes of uncovering new therapies for farmers with respiratory disease.
Shireen Rajaram, associate professor, College of Public Health, received a $223,231 subcontract to reduce risk factors, prevent and delay chronic disease, and promote wellness in children and adults.
Stephen Rennard, M.D., professor, internal medicine, received a $422,730 subcontract to help develop a vaccine for smoking cessation.
Angie Rizzino, Ph.D., professor, Eppley Institute, received $111,375 to examine the molecular mechanisms used to convert adult cells to adult stem cells.
Steven Sansom, Ph.D., professor, cellular/integrative physiology, received $90,000 to discover better ways to manage blood sodium content and blood pressure in the elderly by controlling hypertension and other conditions.
Dhirendra Singh, Ph.D., professor, ophthalmology and visual sciences, received $371,250 to evaluate the use of substances that counteract oxidative stress to delay cataract formation and other degenerative diseases.
Shelley Smith, Ph.D., professor, Munroe-Meyer Institute, received two subcontracts: $81,170 to advance understanding and individual variation in specific language impairments, and $97,232 to further study the etiology and remediation of reading disabilities and ADHD.
Joyce Solheim, Ph.D., associate professor, Eppley Institute, received $89,605 to better understand how the body’s cells alert the immune system if they are cancerous or infected with viruses.
Tahir Tahirov, Ph.D., professor, Eppley Institute, was awarded $226,931 to discover novel therapies for preventing and treating leukemia and other cancers.
Sarah Thompson, Ph.D., professor, College of Nursing, received $9,242 for a program that provides loans to students enrolled in advanced degree nursing programs.
Wallace Thoreson, Ph.D., professor of ophthalmology and visual sciences, and pharmacology and experimental neuroscience, received $90,082 to further examine the movements of single molecules in the development of blindness.
Steven Tracy, Ph.D., professor of pathology and microbiology, was awarded a $130,526 subcontract to study the relationship between enterovirus infections and type 1 Diabetes development.
James Turpen, Ph.D., professor, genetics, cell biology and anatomy, received three grants totaling $1,452,386 to: 1) study the genes and factors contributing to obesity; 2) provide training opportunities in chemistry and biology to undergraduate and graduate students, and 3) further develop the research capacity and infrastructure in Nebraska by building the state's research base and capacity, providing research opportunities for undergraduate students, enhancing science and knowledge of the state's workforce and serving as a pipeline for students to enter health research careers.
Kay-Uwe Wagner, Ph.D., associate professor, Eppley Institute, received $197,273 to determine how altering gene expression affects the onset and progression of breast cancer.
Hongmei Wang, Ph.D., assistant professor, College of Public Health, received two subcontracts worth $991,275 to improve and promote health and wellness in Nebraska.
Feng Xie, M.D., research assistant professor, internal medicine, received $188,363 to develop non-invasive treatment to improve the outcome of patients suffering from heart conditions and stroke.
Jialin Zheng, M.D., professor, pharmacology & experimental neuroscience, received $144,460 to identify new therapeutic strategies for treating HIV-1 associated dementia and other neurodegenerative disorders.
Irving H. Zucker, Ph.D., professor and chair of the department of cellular and integrative physiology, received $771,758 to determine if statins benefit patients with chronic heart failure and to uncover new therapies for heart failure patients.